TONIX PHARMACEUTICALS HOLDING CORP. Income (Loss) from Continuing Operations before Income Taxes, Domestic
TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$34.03 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-03-12
- TONIX PHARMACEUTICALS HOLDING CORP. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was -$34.03M.
- TONIX PHARMACEUTICALS HOLDING CORP. income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was -$80.59M.
- TONIX PHARMACEUTICALS HOLDING CORP. income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was -$18.45M.
- TONIX PHARMACEUTICALS HOLDING CORP. income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was -$21.74M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$34.03M 10-K · filed 2026-03-12 | |
| 2024-12-31 | -$80.59M 10-K · filed 2026-03-12 | |
| 2023-12-31 | -$18.45M 10-K · filed 2025-03-18 | |
| 2022-12-31 | -$21.74M 10-K · filed 2024-04-01 | |
| 2021-12-31 | -$18.60M 10-K · filed 2023-03-13 | |
| 2020-12-31 | -$9.31M 10-K · filed 2022-03-14 | |
| 2019-12-31 | -$5.99M 10-K · filed 2021-03-15 | |
| 2018-12-31 | -$4.59M 10-K · filed 2020-03-24 | |
| 2017-12-31 | -$633.00K 10-K · filed 2019-03-18 | |
| 2016-12-31 | -$4.72M 10-K · filed 2018-03-09 | |
| 2015-12-31 | -$2.75M 10-K · filed 2017-04-13 | |
| 2014-12-31 | -$12.92M 10-K · filed 2016-03-03 | -$14.69M 10-K · filed 2015-02-27 |
| 2013-12-31 | -$10.38M 10-K · filed 2016-03-03 | -$502.05K 10-K · filed 2015-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |